Literature DB >> 31063316

FKBP14 kyphoscoliotic Ehlers-Danlos Syndrome in adolescent patient: the first Colombian report.

Felipe Ruiz-Botero1, Diana Ramírez-Montaño2, Harry Pachajoa2,3.   

Abstract

Ehlers-Danlos syndrome (EDS) is a group of clinically and genetically heterogeneous inherited connective tissue disorders, characterized by skin hyperextensibility, poor wound healing, joint hypermobility and tissue friability. Since 1997 a new spectrum of novel rare EDS-variants has been described, among which is included the EDS kyphoscoliotic type, characterized by severe muscular hypotonia at birth, severe progressive kyphoscoliosis, osteopenia, fragile eyeballs and vascular fragility. This EDS variant is caused by mutations in the PLOD1 gene; however, a rare recessive variant that compromises the FKBP14 gene has been reported, with additional clinical findings that includes gross motor developmental delay, myopathy, hearing impairment and a normal ratio of lysyl pyridinoline to hydroxylysyl pyridinoline in urine. We report the first Colombian patient with a FKBP14 c.362dupC mutation, with clinical features that include generalized hypotonia, delayed gross motor milestones, hearing loss, early-onset progressive kyphoscoliosis, joint hypermobility and foot deformities. Sociedad Argentina de Pediatría.

Entities:  

Keywords:  Ehlers Danlos syndrome; Molecular pathology; Spinal curvature

Mesh:

Substances:

Year:  2019        PMID: 31063316     DOI: 10.5546/aap.2019.eng.e274

Source DB:  PubMed          Journal:  Arch Argent Pediatr        ISSN: 0325-0075            Impact factor:   0.635


  1 in total

1.  Ehlers-Danlos syndrome kyphoscoliotic type 2 caused by mutations in the FKBP14 gene: an analysis of five cases.

Authors:  Alla Nikolaevna Semyachkina; Ekaterina Alexandrovna Nikolaeva; Nailya Mansurovna Galeeva; Alexander Vladimirovich Polyakov; Maria Andreevna Kurnikova; Vera Аlexandrovna Belova; Irina Valerievna Shulyakova; Ilya Sergeevich Dantsev; Goar Vladimirovna Dzhivanshiryan
Journal:  F1000Res       Date:  2021-06-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.